The book is currently out of stock
More about the book
This book presents a universal framework for benefit-risk decisions in pharmaceuticals, addressing the need for a structured approach. It reviews current methodologies and evaluates their effectiveness, offering insights from regulatory authorities. The aim is to create a harmonized system for global benefit-risk assessment.
Book purchase
Benefit-Risk Assessment of Medicines, James Leong, Sam Salek, Stuart Walker
- Language
- Released
- 2015
We’ll email you as soon as we track it down.
Payment methods
No one has rated yet.